Agile Therapeutics Inc. plans to sell its common shares, subject to market and other conditions, in an underwritten public offering.

The company plans to grant the underwriters an option to buy an additional 15% of the shares offered.

William Blair, RBC Capital Markets and Cantor Fitzgerald & Co. are joint book-running managers for the offering.